In vivo effect of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil GM-CSF receptors. 1995

A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
Dipartimento di Scienze Biomediche ed Oncologie Umana, Italy.

The effect of in vivo administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on neutrophils GM-CSF receptor, was investigated in patients with neoplastic diseases and normal hematopoiesis. Patients were divided into two groups. Group A received a single dose of rhGM-CSF (5 micrograms/kg/day) and receptor studies were performed 90 min and 48 h after treatment. Group B received three doses, administered subcutaneously every 24 h and receptor studies were performed 90 min after first injection and 24 h after the last. Before treatment neutrophils only displayed high-affinity receptors (KD 85 +/- 53 pM; number of receptors/cell 1318 +/- 567). The first injection of rhGM-CSF produced a transient leucopenia and the internalization of GM-CSF receptor on neutrophils in both groups of patients: 90 min after s.c. administration receptors could not be detected with conventional binding studies. In group A patients, 48 h after a single dose of rhGM-CSF, receptors, albeit with a decreased affinity (KD = 240 +/- 131 pM; number of receptors/cell 783 +/- 494) were again expressed. In group B patients, 24 h after the last rhGM-CSF injection, low intermediate affinity receptors not present before treatment appeared (KD 720 +/- 175 pM; number of receptor/cell 1222 +/- 179). They were associated with a low number of high affinity receptors (KD = 9 +/- 4 pM; number of receptors/cell 106 +/- 44). These observations indicate that more than one type of GM-CSF receptor may exist on neutrophils. It may be suggested that in vivo the regulation of the GM-CSF receptor is different from that in vitro and is related to the presence of the cytokine in patient blood.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016178 Granulocyte-Macrophage Colony-Stimulating Factor An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. CSF-GM,Colony-Stimulating Factor, Granulocyte-Macrophage,GM-CSF,Histamine-Producing Cell-Stimulating Factor,CSF-2,TC-GM-CSF,Tumor-Cell Human GM Colony-Stimulating Factor,Cell-Stimulating Factor, Histamine-Producing,Colony Stimulating Factor, Granulocyte Macrophage,Granulocyte Macrophage Colony Stimulating Factor,Histamine Producing Cell Stimulating Factor,Tumor Cell Human GM Colony Stimulating Factor
D016187 Receptors, Granulocyte-Macrophage Colony-Stimulating Factor Receptors that bind and internalize the granulocyte-macrophage stimulating factor. Their MW is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor. Antigens, CD116,CD116 Antigens,GM-CSF Receptors,CD116 Antigen,GM-CSF Receptor,Receptor, Granulocyte-Macrophage Colony-Stimulating Factor,Receptors, GM-CSF,Antigen, CD116,GM CSF Receptor,GM CSF Receptors,Receptor, GM-CSF,Receptor, Granulocyte Macrophage Colony Stimulating Factor,Receptors, GM CSF,Receptors, Granulocyte Macrophage Colony Stimulating Factor

Related Publications

A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
January 1992, Immunology series,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
March 1992, Blood reviews,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
August 1994, The Journal of dermatology,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
January 1990, Progress in clinical and biological research,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
January 1998, Pediatric hematology and oncology,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
January 1990, Progress in clinical and biological research,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
January 1990, Progress in clinical and biological research,
A Stacchini, and L Fubini, and E Gatti, and L Mutti, and W Piacibello, and F Sanavio, and G Scagliotti, and E Pozzi, and M Aglietta
November 1999, American journal of reproductive immunology (New York, N.Y. : 1989),
Copied contents to your clipboard!